Stock Analysis
Krynica Vitamin Third Quarter 2023 Earnings: EPS: zł0.38 (vs zł0.41 in 3Q 2022)
Krynica Vitamin (WSE:KVT) Third Quarter 2023 Results
Key Financial Results
- Revenue: zł117.4m (up 11% from 3Q 2022).
- Net income: zł4.67m (down 6.2% from 3Q 2022).
- Profit margin: 4.0% (down from 4.7% in 3Q 2022). The decrease in margin was driven by higher expenses.
- EPS: zł0.38 (down from zł0.41 in 3Q 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Krynica Vitamin shares are up 6.0% from a week ago.
Risk Analysis
Before we wrap up, we've discovered 3 warning signs for Krynica Vitamin that you should be aware of.
Valuation is complex, but we're here to simplify it.
Discover if Krynica Vitamin might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About WSE:KVT
Krynica Vitamin
Produces and sells non-alcoholic and low-alcoholic beverages in Poland, Germany, the United Kingdom, the Czech Republic, Slovakia, and internationally.